Advertisement

Topics

To Study the Prevalence of Insomnia in Geriatric COPD Patients Who Are Enrolled in a Pulmonary Rehabilitation Program.

2014-08-27 03:43:43 | BioPortfolio

Summary

The goal for COPD patients in pulmonary rehabilitation programs is to improve the quality of life. COPD is known to be worse at night as are other respiratory problems such as CHF. Saturation is known to get worse nocturnally as well. Furthermore, these COPD rehabilitation patients tend to be older and increasing age is associated with an increase in the incidence of sleep disorders. We suspect that there is an increase in the incidence of sleep disorders in COPD patients. We plan to further study these patients using questionnaires. A preliminary study was done, but the results were not comparable to national statistics. We plan to repeat the study, only changing the questions to a format comparable to data from the National Sleep Foundation.

Description

Hackensack University Medical Center Institutional Review Board

PROTOCOL: To study the prevalence of insomnia in geriatric COPD patients who are enrolled in a pulmonary rehabilitation program.

I. OBJECTIVES OF THE STUDY

RATIONALE:

The goal for geriatric patients with COPD and enrolled in pulmonary rehabilitation programs is to improve the quality of life. COPD is known to be worse at night as are other respiratory problems such as CHF. Saturation is known to get worse nocturnally as well. Furthermore, these COPD rehabilitation patients tend to be older, and increasing age is associated with an increase in the incidence of sleep disorders. We suspect that there is an increase in the incidence of difficulty initiating and maintaining sleep in COPD patients. A preliminary study was done by the chest medicine specialist in our group, but the results were not comparable to national statistics and were inconclusive. We plan to further evaluate the geriatric COPD patients in pulmonary rehabilitation with initial screening questionnaire and diagnostic screening questionnaires (MMSE, Beck's Anxiety Inventory, Beck's Depression Inventory, and Epworth Sleepiness Scale).

GOALS:

- To determine the incidence and prevalence of insomnia (difficulty initiating sleep (DIS), and/or difficulty maintaining sleep (DMS) in the geriatric population with COPD in a rehabilitation program.

- To determine how many of these patients suffer from anxiety and/or depression.

HYPOTHESIS:

The incidence of insomnia (DIS and/or DMS), along with anxiety/depression is more prevalent in geriatric patients with COPD.

II. BACKGROUND MATERIAL According to the American Academy of Sleep Medicine (AASM), over a six-month period, 20 million Americans complained of insomnia.

COPD patients tend to have decreased total sleep time (32% reported total sleep time less than 6 hours). According to previous studies conducted, the following was reported:

- 15% reported to have insomnia;

- 28% reported poor quality sleep due to anxiety and/or depression;

- 12% reported > 3 awakenings due to unknown origin.

RESULTS OF PILOT:

In the pilot study, a preliminary general (initial) questionnaire was used and will continue to be used as a tool for general screening purposes. And diagnostic questionnaires will be used, which are the following:

- Beck's Anxiety Inventory

- Beck's Depression Inventory

- Epworth Sleepiness Scale

- MMSE

III. DRUG INFORMATION

No drugs are used in this study protocol.

IV. INCLUSIONARY CRITERIA

Geriatric patients with COPD enrolled in the rehabilitation program with FEV1<60%.

V. EXCLUSIONARY CRITERIA

Geriatric patients without a clear diagnosis of COPD. Geriatric patients whose FEV1>60%. Geriatric patients who are unable to answer the questionnaire.

VI. RECRUITMENT PROCEDURES

Geriatric patients in the HUMC pulmonary rehabilitation program who consent to answer the questionnaire and with an FEV1<60% will be enrolled.

VII. METHODOLOGY

Screening: Charts will be reviewed to see which patients meet the criteria of the study.

Informed Consent: If the patient is eligible for diagnostic screening, then an informed consent will be taken.

Randomization: None

Baseline evaluation: Geriatric patients will be asked the questions in the questionnaire.

Follow-up: If insomnia is found, patient will be referred for further treatment.

Withdrawal and Termination: The patient is unable to complete the questionnaire.

VIII. DISCOMFORT AND RISKS

No direct risks to the patient. Failure to follow-up in the clinic if indicated could be problematic.

IX. BENEFITS

Recognition and treatment of sleep problems in this group of patients will add to our understanding of problems in COPD.

X. CRITERIA FOR EVALUATING RESPONSE

No response anticipated from the study protocol.

XI. CONFIDENTIALITY

All results will be kept confidential. Data will only be used by the investigators. Data can be reviewed by the IRB at any time. HIPPA forms will be used for the patient's permission.

XII. PRIMARY INVESTIGATOR

Hormoz Ashtyani, M.D.

CO PRIMARY INVESTIGATOR

Susan Zafarlotfi Ph.D

GERIATRIC MEDICINE SPECIALIST

Knight R. Steel, M.D.

RESEARCH COORDINATOR

Mohammad Quadri, M.D. (MBA) RPSGT

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Conditions

COPD

Location

Hackensack University Medical Center - Pulmonary Rehabilitation
Hackensack
New Jersey
United States
07601

Status

Completed

Source

Hackensack University Medical Center

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-08-27T03:43:43-0400

Clinical Trials [944 Associated Clinical Trials listed on BioPortfolio]

KOrea COpd Subgroup Registry and Subtype Research

The KOrea COpd Subgroup Study team (KOCOSS) cohort is an ongoing, longitudinal, prospective, non-interventional and observational study within the Korean COPD patients. The prevalence of e...

Osteoporosis and Chronic Obstructive Pulmonary Disease (COPD)

The goals of the trial are: - To determine the prevalence of osteoporosis in subgroups of COPD patients. - To look for risk factors of osteoporosis in COPD patients. - To...

COPD Metabolome, Smoking Oxidants and Aberrant Ciliated Cell Function

Cigarette smoking is the major cause of chronic obstructive pulmonary disease (COPD), the 4th cause of mortality in the US. Central to COPD pathogenesis is "ciliopathy", dysfunction of the...

Biomarkers for Diagnosis and Treatment of COPD

COPD is an inflammatory disease characterized by enhanced chronic airway and lung inflammatory responses to noxious agents (e.g. smoke, pollutants) and progressive airflow limitation. In C...

Association of COPD Maintenance Medication Adherence With Resource Use and Cost Among COPD Patients

The aim of this study is to examine the association of COPD maintenance inhalation medication (Inhaled Corticosteroid or ICS) adherence with COPD exacerbation healthcare resource utilizati...

PubMed Articles [455 Associated PubMed Articles listed on BioPortfolio]

Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts.

Thrombocytosis has been associated with COPD prevalence and increased all-cause mortality in patients with acute exacerbation of COPD (AECOPD); but whether it is associated with morbidity in stable CO...

Improving physical activity, sedentary behaviour and sleep in COPD: perspectives of people with COPD and experts via a Delphi approach.

Little is known about how to achieve enduring improvements in physical activity (PA), sedentary behaviour (SB) and sleep for people with chronic obstructive pulmonary disease (COPD). This study aimed ...

Resource use during the last 6 months of life among COPD patients: a population level study.

Chronic obstructive pulmonary disease (COPD) patients often have several comorbidities, such as cardiovascular diseases (CVD) or lung cancer (LC), which might influence resource use in the final month...

Prevalence of Pain in Copd Patients and Associated Factors: Report From a Population Based Study.

To assess the prevalence of chronic neck pain(CNP), chronic low back pain(CLBP) and migraine among Spanish adults with chronic obstructive pulmonary disease(COPD) compared with non-COPD subjects match...

Comprehensive patterns of comorbidity: copd and depression. Aspects of treatment.

Introduction: Data on the prevalence of psychopathological disorders in the exacerbation of chronic obstructive pulmonary disease (COPD) are very heterogeneous. COPD and depression have common predisp...

Medical and Biotech [MESH] Definitions

A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.

More From BioPortfolio on "To Study the Prevalence of Insomnia in Geriatric COPD Patients Who Are Enrolled in a Pulmonary Rehabilitation Program."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

COPD (chronic obstructive pulmonary disease)
COPD (chronic obstructive pulmonary disease) is used for a number of conditions including chronic bronchitis and emphysema, which all  lead to the airways in the lungs becoming damaged and thus narrower,  making inhalation and exhalation harder...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...


Searches Linking to this Trial